Health Technology Expert Review Panel

The Health Technology Expert Review Panel is an advisory body to CADTH, convened to develop guidance and/or recommendations on non-drug health technologies to inform a range of stakeholders within the Canadian health care system.

The approach of the Panel is evidence based and uses a multi-criteria framework that considers the strength and quality of available clinical evidence, the strength and quality of available economic information, current practices and resource utilization patterns, and other factors including, but not limited to, patient input and practical, ethical, environmental, and psychosocial considerations.

The Panel consists of five Core Members appointed to serve for all topics under consideration. In addition, specialists will be appointed on a per-project basis to provide subject matter expertise on specific topics. Core Members include individuals with qualifications in evidence-based medicine and/or critical appraisal, including a Chair, an ethicist, a health economist, a health care practitioner, and one Public Member who represents the broad public interest.

The Health Technology Expert Review Panel reports to the CADTH President and CEO. Committee members must abide by the Conflict of Interest Guidelines for Committee and Panel members and by the CADTH Code of Conduct. An honorarium is paid to the Health Technology Expert Review members for their preparation and meeting time.

Terms of Reference

	Devidas Menon, MHSA, PhD, BScDr. Dr. Devidas Menon is professor of health policy and management at the University of Alberta. He was the founding Executive Director of the Canadian Coordinating Office for Health Technology Assessment (CCOHTA; now CADTH), and Alberta’s Board representative to CCOHTA for one year. He was also a member of  the National Advisory Council of the California Health Benefits Program, set up to generate evidence to support California state decisions on new health programs. He chaired the Alberta Implementation Committee for HTA, producing a blueprint for the province’s HTA program. Currently, he sits on Alberta’s Advisory Committee on Health Technologies, which oversees evidence production to support decisions on non-drug technologies in Alberta. Dr. Menon has an extensive publication record in HTA and evidence-informed policy-making. He has held research grants from the Canadian Institutes of Health Research and the Stem Cell Network on introducing innovative health technologies. He teaches a graduate course in HTA and supervises MSc and PhD students in this area. Conflict of Interest Statement
	Stirling Bryan, PhD (Economics, Brunel University, UK) Dr. Stirling Bryan is a university-based, practising health economist who is extensively engaged in informing policy- and decision-making. His career began at St Thomas’ Hospital Medical School and Brunel University (London, UK), after which he became senior lecturer at the University of Birmingham, then full professor. He was leader of the University of Birmingham team that conducted economic analyses for National Institute for Health and Clinical Excellence (NICE), then served for three years as a member of the NICE technology appraisals committee. In 2005, Dr. Bryan was awarded a Commonwealth Fund Harkness Fellowship and spent one year at Stanford University, researching technology coverage decision-making in US health care organizations. Since relocating to Canada in 2008 (as full professor at UBC’s School of Population and Public Health, and Director of the Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute), his focus on policy-relevant research has continued in one of BC’s largest regional health authorities. Conflict of Interest Statement
	Anita Fineberg, LL.B., CIPP/C Anita Fineberg is a sole practitioner and consultant specializing in the areas of privacy, access to information, data security, and information management law. Her practice focuses on health information privacy, compliance with Ontario's Personal Health Information Protection Act, the federal Personal Information Protection and Electronic Documents Act, and the use of health information in the development of electronic medical and health records. She has extensive experience in drafting and negotiating agreements for the health sector, and assists clients in the development of privacy compliance programs, including policies, procedures, and training. Anita provides emerging companies with advice on online privacy policies, Terms of Use, and rules governing the use of user-generated content on websites. She holds a BA (Hons., Psychobiology) from Queen's University, a LL.B. degree from the University of Toronto, and is a designated Certified Information Privacy Professional. She teaches Health Law at George Brown College and is a frequent speaker, workshop leader, and author on privacy and information security issues. Conflict of Interest Statement
	Charlotte Moore, MD, FRCPC, FAAP Dr. Charlotte Moore is the Lead for the Child Health Policy Initiative at the Hospital for Sick Children, an Assistant Professor of Paediatrics in the Department of Paediatrics at the University of Toronto, and a practising paediatrician in the Division of Paediatric Medicine. Recently, Dr. Moore served as the Provincial Lead for Maternal, Child and Youth Health Strategy in the Office of the Assistant Deputy Minister, at the Ontario Ministry of Health and Long-Term Care.  Conflict of Interest Statement
	Lisa Schwartz